Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 3 to \< 8 years~2. Amblyopia associated with strabismus, anisometropia, or both~3. Visual acuity, measured in each eye without cycloplegia within 7 days prior to enrollment using the ATS single-surround HOTV letter protocol as follows:~   * Visual acuity in the amblyopic eye between 20/100 and 20/400 inclusive~  * Visual acuity in the sound eye 20/32 or better~4. Spectacle correction (if applicable) for measurement of enrollment visual acuity must meet the following criteria and be based on a cycloplegic refraction within 6 months:~   * Requirements for spectacle correction:~  * For patients meeting criteria for only strabismus i. Hypermetropia if corrected must not be undercorrected by more than +1.50 D spherical equivalent, and the reduction in plus sphere must be symmetric in the two eyes. Otherwise, spectacle correction is at investigator discretion.~  * For patients meeting criteria for anisometropia or combined-mechanism i. Spherical equivalent must be within 0.50 D of fully correcting the anisometropia ii. Hypermetropia must not be undercorrected by more than +1.50 D spherical equivalent, and reduction in plus must be symmetric in the two eyes iii. Cylinder power in both eyes must be within 0.50 D of fully correcting the astigmatism iv. Cylinder axis in the spectacle lenses in both eyes must be within 6 degrees of the axis of the cycloplegic refraction~5. Wearing optimal spectacle correction for a minimum of 4 weeks at the time of enrollment.~6. Gestational age \> 34 weeks and birth weight \> 1500 grams~7. Parent willing to accept randomization~8. Parent willing to be contacted and has access to phone~9. Parent does not anticipate relocation outside area of active study site~Exclusion Criteria:~* • Amblyopic eye has myopia worse than -3.00D spherical equivalent.~  * Previous amblyopia treatment within 6 months.~ * Prior intraocular or refractive surgery~ * Known skin reactions to patch or bandage adhesives~ * Systemic diseases that may cause reduced vision such as Down syndrome.~If patients are in the deprivation amblyopia category, the following criteria must be met for the patient to be enrolled in the study:~1. Age 3 to \< 8 years~2. Amblyopia due to previous congenital or developmental cataract surgery.~3. Visual acuity, measured in each eye without cycloplegia within 7 days prior to enrollment using the ATS single-surround HOTV letter protocol as follows:~a. Visual acuity in the amblyopic eye between 20/40 and 20/400 inclusive b. Visual acuity in the sound eye 20/32 or better c. Inter-eye acuity difference ≥ 2 logMAR lines (i.e., amblyopic eye acuity at least 3 lines worse than sound eye acuity) d) Gestational age \> 34 weeks and birth weight \> 1500 grams e) Parent willing to be contacted and has access to phone.~If patients are enrolled in the myopic anisometropia amblyopia category, the following criteria must be met for the patients to be enrolled in the study.~* Aged 3 to \<8 years~* Best-corrected VA in the amblyopic eye of 20/40 to 20/400 inclusive~* Best-corrected VA in the fellow eye of 20/40 or better~* Magnitude of myopic anisometropia of \> 3.00 D~* Intereye acuity difference of \> 3 logMAR lines~* Amblyopia associated with myopic anisometropia~* Has been wearing optimal spectacle correction for a minimum of four weeks

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 8 Years
- Healthy Volunteers: f

Study Arms:
- 12-hour IO-therapy Glasses (Type: EXPERIMENTAL): wear IO-therapy glasses for 12-hour
- 6-hour patching (Type: ACTIVE_COMPARATOR): wear the eye patch for 6-hour

Based on this trial design, predict the completion outcome and termination type (if applicable).